XLS-MEDICAL MAX STRENGTH. Up to 33% more effective*

XLS-MEDICAL MAX STRENGTH

  • Reach your weight loss goal even faster*
  • First slimming aid to reduce calorie intake from carbohydrates, sugar and fat
  • Clinically Proven. Gentle on your system
*Grube et al 2013. (Data on file)
XLS Medical Direct Fat Binder

XLS-MEDICAL
DIRECT FAT BINDER

  • Binds some dietary fat
  • No need for water
  • Clinically proven


XLS Medical Fat Binder. voted product of the year

XLS-MEDICAL
FAT BINDER

  • Binds some dietary fat
  • Gentle on your system
  • Clinically proven


XLS Carb Blocker

NEW XLS-MEDICAL
CARB BLOCKER

  • Helps reduce calories absorbed from ditary carbohydrates
  • Suitable for those with carb-rich diets
  • Clinically proven

READY TO FIND THE RIGHT WEIGHT-LOSS OPTION FOR YOU?

Find out now

Which of the below most applies to your diet?

  • 1

    I regularly eat foods like cheese, butter, fried food, and things like sausages and burgers

  • 1

    I regularly eat foods like white bread, pasta, chips, sugary cereals, and treats like cakes and biscuits

  • 1

    I enjoy creamy or rich dressings with my salads and/or sandwiches

RECOMMENDED FOR YOU

RECOMMENDED FOR YOU

RECOMMENDED FOR YOU

XLS-MEDICAL APPETITE REDUCER. 94% of people experienced a feeling of fullness

XLS-MEDICAL APPETITE REDUCER

  • Control your hunger
  • Great to use with meal replacements
  • Clinically proven

Copyright 2017

Max Strength Clinical Study Reference: *Grube et al. 2015. IQP-VV-102, a Novel Proprietary Composition for Weight Reduction: A Double-Blind Randomized Clinical Trial for Evaluation of Efficacy and Safety. Evidence-Based Complementary and Alternative Medicine, 2015:1-7. doi: 10.1155/2015/413075

Fat Binder Clinical Study Reference: *Grube et al. (2013). A natural fiber complex reduces body weight in the overweight and obese: a double-blind, randomized, placebo-controlled study. Obesity . 21 (1), 58-64. doi:10.1038/oby.2012.165.

Carb Blocker Clinical Study Reference: *Grube et al. 2013. Weight Reduction and Maintenance with IQP-PV-101: A 12-Week Randomized Controlled Study with a 24-Week Open Label Period.

*Individual results will vary.